Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease

Neurotherapeutics(2022)10.1007/s13311-022-01182-2Source: DataRank Database

Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease is a research paper published in Neurotherapeutics (2022). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)OA: hybridTopics (37)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Anna Ena,Chiara Burgaletto ORCID,Maria Antonietta Casu ORCID,Giuseppina Cantarella ORCID,Ezio Carboni ORCID

Live enrichment

PubMed:35072912 PMC:PMC9130415

National Institute on Aging

Grant: Intramural Research Program of the National Institute on Aging

National Institute on Aging

Grant: National Institutes of Health

National Institute on Aging

Grant: Baltimore

National Institute on Aging

Grant: MD

National Institute on Aging

Grant: United States

University of Cagliari

Grant: Intramural Research Program at the University of Cagliari

European Research Council

Grant: ERC CoG BioDisOrder 819644

European Research Council

Grant: 819644

Order and Disorder at the Surface of Biological Membranes.

hybridLicense: cc-by

publisherhttps://link.springer.com/content/pdf/10.1007/s13311-022-01182-2.pdf

publisherhttps://link.springer.com/article/10.1007/s13311-022-01182-2/fulltext.html

publisherhttps://api.elsevier.com/content/article/PII:S1878747923001691?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1878747923001691?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9130415

Fields of Study

0301 basic medicine03 medical and health sciences0302 clinical medicine

MeSH Terms

Substantia NigraMicrogliaAnimalsHumansRatsParkinson DiseaseDisease Models, AnimalDisease ProgressionThalidomideTumor Necrosis Factor-alphaNeuroprotective AgentsCytokinesalpha-SynucleinDrug Repositioning

Keywords

CytokineImmunomodulationneuroprotectionalpha-SynucleinMotor ImpairmentDrug RepositioningAnimalsHumansAlpha-synuclein; Cytokine; Drug repositioning; Immunomodulation; Motor impairment; NeuroprotectionTumor Necrosis Factor-alphaParkinson DiseaseRatsThalidomideSubstantia NigraDisease Models, AnimalNeuroprotective AgentsDisease ProgressionCytokinesOriginal ArticleMicroglia

Sustainable Development Goals

SDG 3: 3. Good health